Literature DB >> 17646842

The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable.

J-M Tiercy1, G Nicoloso, J Passweg, U Schanz, R Seger, Y Chalandon, D Heim, T Güngör, P Schneider, R Schwabe, A Gratwohl.   

Abstract

Identification of an unrelated HLA allele-matched hematopoietic stem cell (HSC) donor is a costly and time-consuming procedure. To improve search logistics, we have limited the search period to 6 months and have introduced a probability estimate of the chances of identifying a 10/10 HLA allele-matched donor. Probabilities were classified as high (>95%), intermediate (50%) and low (<5% chance) based on allele and haplotype frequencies. By analyzing 350 consecutive searches between 2002 and 2005 (1719 donors tested), the probability estimates turned out to be correct for 96% (high), 88% (low) and 56% (intermediate) patients. For searches with a high probability of success, at least one of the 10 most frequent haplotypes in Caucasoids was found in 69% of the patients, but in only 11% of the patients with a low-probability estimate (P<0.00001). Survival probability at 3 years was significantly higher for HSCT patients classified with a high-probability estimate when compared to patients in the intermediate/low-probability groups (74 vs 51 and 54% respectively, P=0.01). The same difference in survival probabilities was observed when only 10/10 matched unrelated HSCT patients were analyzed. In the intermediate-/low-probability groups, patients with alternative (haploidentical, autologous) or mismatched unrelated donors had similar survival estimates. Probability prediction is therefore feasible in the search process for unrelated donors and can guide the therapeutic strategy.

Entities:  

Mesh:

Year:  2007        PMID: 17646842     DOI: 10.1038/sj.bmt.1705787

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  11 in total

1.  Unrelated donor search prognostic score to support early HLA consultation and clinical decisions.

Authors:  K Wadsworth; M Albrecht; R Fonstad; S Spellman; M Maiers; J Dehn
Journal:  Bone Marrow Transplant       Date:  2016-06-06       Impact factor: 5.483

2.  High-resolution HLA matching in unrelated donor transplantation in Switzerland: differential impact of class I and class II mismatches may reflect selection of nonimmunogenic or weakly immunogenic DRB1/DQB1 disparities.

Authors:  J R Passweg; U Schanz; Y Chalandon; T Güngör; H Baldomero; D Heim; G Nair; M Medinger; S Masouridi-Levrat; G N de Faveri; J-M Tiercy
Journal:  Bone Marrow Transplant       Date:  2015-06-08       Impact factor: 5.483

3.  The Austrian Bone Marrow Donor Registry: Providing Patients in Austria with Unrelated Donors for Transplant - a Worldwide Cooperation.

Authors:  Agathe Rosenmayr; Margit Pointner-Prager; Martina Winkler; Andrea Mitterschiffthaler; Barbara Pelzmann; Ljiljana Bozic; Sonja-Kurzweil Pichler; Heinz Tüchler; Ingrid Fae; Gottfried Fischer
Journal:  Transfus Med Hemother       Date:  2011-09-22       Impact factor: 3.747

4.  The increase of the global donor inventory is of limited benefit to patients of non-Northwestern European descent.

Authors:  Suzanna M van Walraven; Anneke Brand; Jack N A Bakker; Martin B A Heemskerk; Suzan Nillesen; Marc B Bierings; Laura B Bungener; Bouke G Hepkema; Arjan Lankester; Arnold van der Meer; Kees Sintnicolaas; Judith A E Somers; Eric Spierings; Marcel G J Tilanus; Christien E M Voorter; Jan J Cornelissen; Machteld Oudshoorn
Journal:  Haematologica       Date:  2016-08-25       Impact factor: 9.941

5.  Support of unrelated stem cell donor searches by donor center-initiated HLA typing of potentially matching donors.

Authors:  Alexander H Schmidt; Ute V Solloch; Daniel Baier; Alois Grathwohl; Jan Hofmann; Julia Pingel; Andrea Stahr; Gerhard Ehninger
Journal:  PLoS One       Date:  2011-05-20       Impact factor: 3.240

6.  High-resolution HLA phased haplotype frequencies to predict the success of unrelated donor searches and clinical outcome following hematopoietic stem cell transplantation.

Authors:  Stéphane Buhler; Helen Baldomero; Sylvie Ferrari-Lacraz; José Manuel Nunes; Alicia Sanchez-Mazas; Stravroula Massouridi-Levrat; Dominik Heim; Jörg Halter; Gayathri Nair; Yves Chalandon; Urs Schanz; Tayfun Güngör; Grazia Nicoloso; Jean-Marie Tiercy; Jakob Passweg; Jean Villard
Journal:  Bone Marrow Transplant       Date:  2019-04-05       Impact factor: 5.483

7.  Unrelated hematopoietic stem cell donor matching probability and search algorithm.

Authors:  J-M Tiercy
Journal:  Bone Marrow Res       Date:  2012-11-13

8.  Molecular monitoring of minimal residual disease in two patients with MLL-rearranged acute myeloid leukemia and haploidentical transplantation after relapse.

Authors:  Thomas Burmeister; Mara Molkentin; Claus Meyer; Nils Lachmann; Stefan Schwartz; Birte Friedrichs; Jörg Beyer; Igor Wolfgang Blau; Gunnar Lohm; Carola Tietze-Bürger; Rolf Marschalek; Lutz Uharek
Journal:  Exp Hematol Oncol       Date:  2012-04-18

9.  Both optimal matching and procedure duration influence survival of patients after unrelated donor hematopoietic stem cell transplantation.

Authors:  Sylwia Mizia; Dorota Dera-Joachimiak; Malgorzata Polak; Katarzyna Koscinska; Mariola Sedzimirska; Andrzej Lange
Journal:  Bone Marrow Res       Date:  2012-10-22

10.  Alternative donor peripheral blood stem cell transplantation for the treatment of high-risk refractory and/or relapsed childhood acute leukemia: a randomized trial.

Authors:  Binglei Zhang; Jian Zhou; Fengkuan Yu; Tianxin Lv; Baijun Fang; Dandan Fan; Zhenyu Ji; Yongping Song
Journal:  Exp Hematol Oncol       Date:  2020-04-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.